Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycograb + Docetaxel in Metastatic/Recurrent Breast Cancer
NCT00217815Phase 2Completed
- Sponsor
- Neutec Pharmaceuticals
- Start
- Sep 2005
- Modality
- scFv Fragments, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of efungumab in breast cancer, sponsored by Neutec Pharmaceuticals. Started Sep 2005; status: completed.
02
Drugs
efungumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00217815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00217815.